JP2026015426A5 - - Google Patents
Info
- Publication number
- JP2026015426A5 JP2026015426A5 JP2025189065A JP2025189065A JP2026015426A5 JP 2026015426 A5 JP2026015426 A5 JP 2026015426A5 JP 2025189065 A JP2025189065 A JP 2025189065A JP 2025189065 A JP2025189065 A JP 2025189065A JP 2026015426 A5 JP2026015426 A5 JP 2026015426A5
- Authority
- JP
- Japan
- Prior art keywords
- nanoparticles
- composition
- polymer
- use according
- polymer nanoparticles
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1918963.8 | 2019-12-20 | ||
| GBGB1918963.8A GB201918963D0 (en) | 2019-12-20 | 2019-12-20 | Polymeric nanoparticles as vaccine adjuvants |
| JP2022538064A JP2023507497A (ja) | 2019-12-20 | 2020-12-21 | ワクチンアジュバントとしてのポリマーナノ粒子 |
| PCT/EP2020/087456 WO2021123430A1 (en) | 2019-12-20 | 2020-12-21 | Polymeric nanoparticles as vaccine adjuvants |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022538064A Division JP2023507497A (ja) | 2019-12-20 | 2020-12-21 | ワクチンアジュバントとしてのポリマーナノ粒子 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2026015426A JP2026015426A (ja) | 2026-01-29 |
| JP2026015426A5 true JP2026015426A5 (https=) | 2026-03-12 |
Family
ID=69322661
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022538064A Pending JP2023507497A (ja) | 2019-12-20 | 2020-12-21 | ワクチンアジュバントとしてのポリマーナノ粒子 |
| JP2025189065A Pending JP2026015426A (ja) | 2019-12-20 | 2025-11-10 | ワクチンアジュバントとしてのポリマーナノ粒子 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022538064A Pending JP2023507497A (ja) | 2019-12-20 | 2020-12-21 | ワクチンアジュバントとしてのポリマーナノ粒子 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20230218752A1 (https=) |
| EP (1) | EP4076519A1 (https=) |
| JP (2) | JP2023507497A (https=) |
| CN (1) | CN115279401A (https=) |
| AU (1) | AU2020407306A1 (https=) |
| CA (1) | CA3162350A1 (https=) |
| GB (1) | GB201918963D0 (https=) |
| WO (1) | WO2021123430A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114657210B (zh) * | 2022-03-03 | 2023-08-11 | 中山大学孙逸仙纪念医院 | 一种基于负载gsdmd蛋白n端肽段的纳米材料及其应用 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4599230A (en) | 1984-03-09 | 1986-07-08 | Scripps Clinic And Research Foundation | Synthetic hepatitis B virus vaccine including both T cell and B cell determinants |
| US4601903A (en) | 1985-05-01 | 1986-07-22 | The United States Of America As Represented By The Department Of Health And Human Services | Vaccine against Neisseria meningitidis Group B serotype 2 invasive disease |
| EP1107783B1 (en) | 1998-09-01 | 2006-04-05 | ELAN CORPORATION, Plc | Method for inducing a cell-mediated immune response and parenteral vaccine formulations therefor |
| US8021689B2 (en) * | 2006-02-21 | 2011-09-20 | Ecole Polytechnique Federale de Lausanne (“EPFL”) | Nanoparticles for immunotherapy |
| US8323696B2 (en) * | 2008-08-29 | 2012-12-04 | Ecole Polytechnique Federale De Lausanne | Nanoparticles for immunotherapy |
| CA2753567C (en) | 2009-02-27 | 2019-12-31 | Toray Industries, Inc. | Immunogenic antigen-adjuvant microparticle complex |
| WO2012054425A2 (en) | 2010-10-18 | 2012-04-26 | University Of Iowa Research Foundation | Biodegradable particulate formulations |
| CN104338126B (zh) * | 2013-08-08 | 2018-05-04 | 中国科学院过程工程研究所 | 一种具有治疗或预防hpv病毒的疫苗组合物及其应用 |
| US10117886B2 (en) | 2014-05-30 | 2018-11-06 | Hao Cheng | Hyaluronidase and a low density second PEG layer on the surface of therapeutic-encapsulated nanoparticles to enhance nanoparticle diffusion and circulation |
| CA3016457A1 (en) * | 2016-03-02 | 2017-09-08 | The Board Of Regents Of The University Of Texas System | Sting activating nanovaccine for immunotherapy |
| US11925693B2 (en) * | 2017-07-27 | 2024-03-12 | The Board Of Trustees Of The Leland Stanford Junior University | Polymeric nanoparticles for enhanced cancer immunotherapy |
-
2019
- 2019-12-20 GB GBGB1918963.8A patent/GB201918963D0/en not_active Ceased
-
2020
- 2020-12-21 CA CA3162350A patent/CA3162350A1/en active Pending
- 2020-12-21 WO PCT/EP2020/087456 patent/WO2021123430A1/en not_active Ceased
- 2020-12-21 EP EP20841918.4A patent/EP4076519A1/en active Pending
- 2020-12-21 US US17/787,051 patent/US20230218752A1/en not_active Abandoned
- 2020-12-21 CN CN202080097299.0A patent/CN115279401A/zh active Pending
- 2020-12-21 AU AU2020407306A patent/AU2020407306A1/en active Pending
- 2020-12-21 JP JP2022538064A patent/JP2023507497A/ja active Pending
-
2025
- 2025-11-10 JP JP2025189065A patent/JP2026015426A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2026015426A5 (https=) | ||
| Malik et al. | Trimethyl chitosan nanoparticles encapsulated protective antigen protects the mice against anthrax | |
| JP6382936B2 (ja) | ナノ粒子ベースの組成物 | |
| Vasiliev | Chitosan-based vaccine adjuvants: incomplete characterization complicates preclinical and clinical evaluation | |
| Gopi et al. | Effective drug delivery system of biopolymers based on nanomaterials and hydrogels-a review | |
| Islam et al. | Design and application of chitosan microspheres as oral and nasal vaccine carriers: an updated review | |
| Rauta et al. | Parenteral immunization of PLA/PLGA nanoparticle encapsulating outer membrane protein (Omp) from Aeromonas hydrophila: Evaluation of immunostimulatory action in Labeo rohita (rohu) | |
| Zhang et al. | Potent antigen-specific immune responses stimulated by codelivery of CpG ODN and antigens in degradable microparticles | |
| JP2006526649A5 (https=) | ||
| JP2010527906A5 (https=) | ||
| JP2016511747A5 (https=) | ||
| JP2012524793A (ja) | 免疫調節性生体分子を組み合わせて送達するためのヒドロゲル | |
| US20220331259A1 (en) | Biodegradable polymeric particles encapsulating an active agent, pharmaceutical compositions and uses thereof | |
| Florindo et al. | New approach on the development of a mucosal vaccine against strangles: systemic and mucosal immune responses in a mouse model | |
| Zhang et al. | Nanotechnology-driven advances in intranasal vaccine delivery systems against infectious diseases | |
| Debnath et al. | Potential application of bionanoparticles to treat severe acute respiratory syndrome coronavirus-2 infection | |
| JP2018515530A5 (https=) | ||
| Johnson et al. | Nanoparticle technology for respiratory tract mucosal vaccine delivery | |
| US9821055B2 (en) | Vaccine adjuvants | |
| Liu et al. | Development of PDA nanoparticles for H9N2 avian influenza BPP-V/BP-IV epitope peptide vaccines: immunogenicity and delivery efficiency improvement | |
| Kakehbaraei et al. | Emerging trends in viral infection inhibition using a chitosan-based drug delivery system | |
| Parmaksız et al. | Carboxymethyl chitosan for drug and vaccine delivery: an overview | |
| Rosales-Mendoza et al. | Chitosan-based mucosal nanovaccines | |
| Rane et al. | Polymer-Based Vaccines | |
| Rosales-Mendoza et al. | Silica-based mucosal nanovaccines |